[go: up one dir, main page]

JPH06197783A - New cyclic isomaltooligosaccharide and its production - Google Patents

New cyclic isomaltooligosaccharide and its production

Info

Publication number
JPH06197783A
JPH06197783A JP34944492A JP34944492A JPH06197783A JP H06197783 A JPH06197783 A JP H06197783A JP 34944492 A JP34944492 A JP 34944492A JP 34944492 A JP34944492 A JP 34944492A JP H06197783 A JPH06197783 A JP H06197783A
Authority
JP
Japan
Prior art keywords
cyclic
isomaltooligosaccharide
bonds
oligosaccharide
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP34944492A
Other languages
Japanese (ja)
Other versions
JP3075873B2 (en
Inventor
Tetsuya Oguma
哲哉 小熊
Tatsuo Horiuchi
達雄 堀内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NODA SANGYO KAGAKU KENKYUSHO
Original Assignee
NODA SANGYO KAGAKU KENKYUSHO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NODA SANGYO KAGAKU KENKYUSHO filed Critical NODA SANGYO KAGAKU KENKYUSHO
Priority to JP34944492A priority Critical patent/JP3075873B2/en
Priority to DE69308531T priority patent/DE69308531T2/en
Priority to EP93310579A priority patent/EP0608636B1/en
Priority to US08/174,596 priority patent/US5364936A/en
Publication of JPH06197783A publication Critical patent/JPH06197783A/en
Priority to US08/284,318 priority patent/US5453369A/en
Application granted granted Critical
Publication of JP3075873B2 publication Critical patent/JP3075873B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

PURPOSE:To provide a new cyclic isomaltooligosaccharide useful e.g. as a clathrating agent for pharmaceuticals, foods, etc. CONSTITUTION:Cycloisomaltoheptaose having cyclic structure formed by bonding 7 glucose molecules through alpha-1, 6 bonds; cycloisomaltooctaose having cyclic structure formed by bonding 8 glucose molecules through alpha-1, 6 bonds; and cycloisomaltononaose having cyclic structure formed by bonding 9 glucose molecules through alpha-1, 6 bonds. The cyclic isomaltooligosaccharide can be produced by culturing a microbial strain which belongs to the genus Bacillus and capable of producing a cyclic oligosaccharide from dextran [e.g. Bacillus sp. T-3040 strain (FERM BP-4132)] in a medium containing alpha-1, 6 glucan and collecting the saccharide from the cultured product.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、新規な環状イソマルト
オリゴ糖及びその製造法に関する。
TECHNICAL FIELD The present invention relates to a novel cyclic isomaltooligosaccharide and a method for producing the same.

【0002】[0002]

【従来の技術】従来、環状オリゴ糖としては、例えば、
グルコース6〜8分子がα−1、4結合したサイクロデ
キストリンが良く知られている。サイクロデキストリン
は、構造的に環の中心部が疎水性を示すため、種々の疎
水性物質と結合する能力(包接能)を有している。その
ため、医薬品、化粧品、食品等の幅広い分野で、種々の
物質の安定化や溶解度等の改善のために、この性質を利
用した応用開発がなされている〔ハンドブック オブ
アミラーゼズ アンド リレイテッド エンザイム(Ha
ndbook of Amylases and Related Enzymes)日本アミラ
ーゼ研究会編、第233 〜243 頁、1988年〕。
2. Description of the Related Art Conventional cyclic oligosaccharides include, for example,
Cyclodextrins in which 6 to 8 glucose molecules are linked by α-1,4 are well known. Cyclodextrin has the ability (inclusion ability) to bind to various hydrophobic substances because the center of the ring is structurally hydrophobic. Therefore, in a wide range of fields such as pharmaceuticals, cosmetics, and foods, application development utilizing this property has been carried out in order to stabilize various substances and improve solubility.
Amylases and Related Enzymes (Ha
ndbook of Amylases and Related Enzymes), Amylase Society of Japan, pp. 233-243, 1988].

【0003】また、最近、フラクトース6〜8分子がβ
−2、1結合した環状オリゴ糖が見出され、サイクロデ
キストリンと同様に幅広い分野での利用が期待されてい
る〔カルボハイドレート・リサーチ(Carbohyd. Res.)
第192 巻、第83〜90頁、1989年〕。これらの糖以外に
も、グルコース17〜24分子がβ−1、2結合したシ
クロソフォラオース、グルコース3〜4分子がβ−1、
6結合したサイクロゲンチオオリゴ糖、ラムノースが6
分子で環状化したサイクロアワオドリン、マンノースが
6分子で環状化したサイクロマンノヘキサオース等の種
々の環状オリゴ糖が酵素的あるいは化学合成により合成
されている。
Recently, 6 to 8 molecules of fructose are β
-2,1 linked cyclic oligosaccharides have been found and are expected to be used in a wide range of fields as with cyclodextrins [Carbohydrate Research (Carbohyd. Res.)
192, 83-90, 1989]. In addition to these sugars, 17-24 molecules of glucose are β-1, 2-linked cyclosophoraose, 3-4 molecules of glucose are β-1,
6-linked cyclogenthiooligosaccharide, rhamnose 6
Various cyclic oligosaccharides such as cycloawaodrin cyclized with molecules and cyclomannohexaose cyclized with 6 molecules of mannose have been synthesized by enzymatic or chemical synthesis.

【0004】しかしながら、グルコースがα−1、6結
合した環状オリゴ糖は、従来全く知られていない。
However, no cyclic oligosaccharide in which glucose is bound to α-1,6 has been known at all.

【0005】[0005]

【発明が解決しようとする課題】本発明の目的は、その
有用性が大いに期待されるグルコースがα−1、6結合
した新規な環状イソマルトオリゴ糖及びその製法を提供
することにある。
DISCLOSURE OF THE INVENTION An object of the present invention is to provide a novel cyclic isomaltooligosaccharide in which glucose is α-1,6 linked, which is expected to be highly useful, and a method for producing the same.

【0006】[0006]

【課題を解決するための手段】そこで、本発明者等は、
デキストランから、環状オリゴ糖を生成する微生物を土
壌より検索した結果、バチルス属に属する1菌株が新規
な環状オリゴ糖を培地中に産生すること等を知見し、本
発明を完成した。
Therefore, the present inventors have
As a result of searching soil for a microorganism that produces a cyclic oligosaccharide from dextran, the inventors have found that one strain belonging to the genus Bacillus produces a novel cyclic oligosaccharide in a medium, and completed the present invention.

【0007】即ち、本発明は、グルコース7分子がα−
1、6結合により環状構造を形成してなる新規なサイク
ロイソマルトヘプタオース、グルコース8分子がα−
1、6結合により環状構造を形成してなる新規なサイク
ロイソマルトオクタオース及びグルコース9分子がα−
1、6結合により環状構造を形成してなる新規なサイク
ロイソマルトノナオースからなる群から選択された新規
な環状イソマルトオリゴ糖である。
That is, in the present invention, 7 molecules of glucose are α-
A novel cycloisomaltoheptaose, which forms a cyclic structure with 1,6 bonds, and 8 molecules of glucose are α-
9 molecules of novel cycloisomaltooctaose and glucose formed by forming a cyclic structure with 1,6 bonds are α-
It is a novel cyclic isomaltooligosaccharide selected from the group consisting of a novel cycloisomaltononaose formed by forming a cyclic structure by 1,6 bonds.

【0008】さらに、本発明は、バチルス属に属し、前
記環状イソマルトオリゴ糖生産能を有する微生物を、α
−1,6グルカンを含有する培地中で培養し、培養物よ
前記環状イソマルトオリゴ糖を採取することを特徴と
する新規な環状イソマルトオリゴ糖の製造法である。
Further, the present invention relates to a microorganism belonging to the genus Bacillus and having the ability to produce cyclic isomaltooligosaccharide,
A novel method for producing a cyclic isomaltooligosaccharide, which comprises culturing in a medium containing -1,6-glucan and collecting the cyclic isomaltooligosaccharide from the culture.

【0009】以下、本発明を詳細に説明する。先ず、こ
れらの物質の理化学的性質及びその性質に基づきこれら
の物質が環状オリゴ糖であることについて説明する。 1.元素分析の結果、以下のようになり各々グルコース
の環状7量体、8量体、9量体であることが判った。 サイクロイソマルトヘプタオース;C42H70O35・3H2
Oとして 計算値 C:42.43% H:6.44 % 測定値 C:42.78% H:6.33 % サイクロイソマルトオクタオース;C48H80O40・4H2
Oとして 計算値 C:42.11% H:6.48 % 測定値 C:42.37% H:6.24 % サイクロイソマルトノナオース ;C54H90O45・5H2
Oとして 計算値 C:41.86% H:6.51 % 測定値 C:41.53% H:6.18 %
The present invention will be described in detail below. First, the physicochemical properties of these substances and the fact that these substances are cyclic oligosaccharides will be explained based on the properties. 1. As a result of elemental analysis, it was found to be as follows, and it was found that they were cyclic heptamers, octamers and 9-mers of glucose. Cyclo iso maltoheptaose; C42H70O35 · 3H 2
Calculated as O C: 42.43% H: 6.44% Measured value C: 42.78% H: 6.33% Cycloisomaltooctaose; C48H80O40 ・ 4H 2
Calculated value as O C: 42.11% H: 6.48% Measured value C: 42.37% H: 6.24% Cycloisomaltononaose; C54H90O45 ・ 5H 2
Calculated as O C: 41.86% H: 6.51% Measured value C: 41.53% H: 6.18%

【0010】2.分子量は、日立製作社製の質量分析計
80Bにより分析したマススペクトル分析のデータから サイクロイソマルトヘプタオース;1134 サイクロイソマルトオクタオース;1296 サイクロイソマルトノナオース ;1458 であり、いずれも分子式から推定される値と一致した。
2. The molecular weight is a mass spectrometer manufactured by Hitachi Ltd.
From the data of the mass spectrum analysis analyzed by 80B, cycloisomaltoheptaose; 1134 cycloisomaltooctaose; 1296 cycloisomaltonononaose; 1458, which were all in agreement with the values estimated from the molecular formula.

【0011】3.融点は、やなぎもと社製の融点測定機
により測定した結果、明確に融解せず、下記の温度域で
変色したので、分解温度を示したが、夫々、 サイクロイソマルトヘプタオース;234〜238℃ サイクロイソマルトオクタオース;238〜241℃ サイクロイソマルトノナオース ;239〜242℃ であった。
3. The melting point was measured by a melting point measuring device manufactured by Yanagimoto Co., Ltd., and it did not melt clearly, and the decomposition temperature was shown because the color changed in the following temperature range, but cycloisomaltoheptaose; 234 to 238, respectively. C. Cycloisomaltooctaose; 238 to 241 ° C Cycloisomaltononaose; 239 to 242 ° C.

【0012】4.紫外線吸収スペクトルは、日立製作社
製の分光光度計 775で測定した結果、いずれも特徴的な
吸収は認められなかった。従って、アミノ基、カルボキ
シル基等の官能基は持っていないことが示唆された。 5.該物質の外赤外線吸収スペクトルを日本分光社製IR
スペクトルメーターモデルFT/IR-7300 で測定した結果
を図1に示した。図1において、A、B、Cはそれぞれ
グルコースの環状7量体、8量体、および9量体を示
す。その結果、いずれもα−1、6結合に特有の917±
2cm-1と768±1cm-1に吸収ピークを示した。従っ
て、該オリゴ糖がα−1、6結合を有していることが示
唆された。
4. The ultraviolet absorption spectrum was measured by a spectrophotometer 775 manufactured by Hitachi Ltd. As a result, no characteristic absorption was observed. Therefore, it was suggested that they do not have functional groups such as amino groups and carboxyl groups. 5. The infrared absorption spectrum of the substance was measured by IR from JASCO Corporation.
The result of measurement with a spectrum meter model FT / IR-7300 is shown in FIG. In FIG. 1, A, B, and C respectively indicate a cyclic heptamer, an octamer, and a 9mer of glucose. As a result, 917 ± peculiar to α-1,6 binding
Absorption peaks were shown at 2 cm-1 and 768 ± 1 cm-1. Therefore, it was suggested that the oligosaccharide has an α-1,6 bond.

【0013】6.溶剤に対する溶解性は、いずれのオリ
ゴ糖も室温で最低20mg/ml以上の濃度で水に溶け
た。 7.呈色反応は、いずれのオリゴ糖もソモギーネルソン
法で発色しなかったことから、還元末端が存在していな
いことを強く示唆している。 8.該物質は、いずれも中性の白色物質である。 9.該物質の日本電子社製のNMR スペクトルメーターモ
デルNM-FX200による13C−NMR分析の結果からいずれ
も、6本のシグナルが認められただけであって、環状構
造を支持していた。また、イソマルトヘプタオースの解
析から、該物質の結合様式がα−1、6結合であること
が強く示唆された。
6. Regarding the solubility in solvents, all oligosaccharides were dissolved in water at room temperature at a concentration of at least 20 mg / ml or more. 7. The color reaction strongly suggested that there was no reducing end, since neither oligosaccharide developed color by the Somogene Nelson method. 8. The substances are all neutral white substances. 9. From the results of 13 C-NMR analysis of the substance by NMR spectrum meter model NM-FX200 manufactured by JEOL Ltd., only 6 signals were recognized in each case, which supported the cyclic structure. Further, the analysis of isomaltheptaose strongly suggested that the binding mode of the substance was α-1,6 binding.

【0014】次に該物質の酵素的解析結果を示す。 10.図2に示したように、1%濃度の該物質に対してエ
キソ型デキストラナーゼであるグルコデキストラナーゼ
を40℃で24時間作用させたが、全く水解されなかった。
尚、同条件下でイソマルトヘキサオース及びイソマルト
ヘプタオースは、完全に水解された。従って、直鎖イソ
マルトオリゴ糖ではないことを示唆している。 11.1%濃度の該物質に対してエンド型デキストラナー
ゼを作用させたところグルコース及びイソマルトースに
まで分解された。従って、これらのオリゴ糖は、グルコ
ースを唯一の構成糖としており、かつα−1、6結合の
みからなることを示唆している。
Next, the results of enzymatic analysis of the substance are shown. Ten. As shown in FIG. 2, glucodextranase, which is an exo-type dextranase, was allowed to act on the substance at a concentration of 1% for 24 hours at 40 ° C., but it was not hydrolyzed at all.
Under the same conditions, isomalthexaose and isomaltheptaose were completely hydrolyzed. Therefore, it is suggested that it is not a linear isomaltooligosaccharide. When the endo-type dextranase was allowed to act on the substance at 11.1% concentration, it was decomposed into glucose and isomaltose. Therefore, it is suggested that these oligosaccharides have glucose as the only constituent sugar and consist of only α-1,6 bonds.

【0015】以上1.〜11.までの結果より、該物質は、
いずれもグルコース7〜9分子がα−1、6結合した、
環状オリゴ糖であると判断された。なお、これら環状イ
ソマルトオリゴ糖の構造式は、次の通りである。
From the above results 1 to 11, the substance is
In each case, 7-9 glucose molecules were bound by α-1,6,
It was determined to be a cyclic oligosaccharide. The structural formulas of these cyclic isomaltooligosaccharides are as follows.

【化1】 [Chemical 1]

【0016】以上詳述した如く、該環状オリゴ糖は、従
来公知の環状オリゴ糖とはその性質を異にし、グルコー
スのα−1、6結合からなる、環状オリゴ糖である点で
全く新しい環状オリゴ糖である。本物質は環状構造であ
るため、包接作用を有しており、サイクロデキストリン
とは、異なったサイズの物質の安定化、可溶化等に有用
である。そして、具体的には医薬品、食品等の包接剤に
用いられる。
As described in detail above, the cyclic oligosaccharide has a property different from that of the conventionally known cyclic oligosaccharide and is a completely novel cyclic oligosaccharide in that it is composed of α-1,6 bonds of glucose. It is an oligosaccharide. Since this substance has a cyclic structure, it has an inclusion action and is useful for stabilizing and solubilizing substances of different sizes from cyclodextrin. And specifically, it is used as an inclusion agent for medicines, foods and the like.

【0017】次に、本物質の製造法について説明する。
本発明において使用される微生物としては、バチルス属
に属し、デキストランから環状オリゴ糖を生成するもの
であれば、如何なる菌株でもよく、例えば、T−304
0菌株がある。このT−3040株は、土壌中から、取
得した野性株である。以下に本菌株の菌学的性質を示
す。菌学的性質 (1)形態 a.形態 桿菌 b.運動性 認められる c.胞子 有 胞子嚢 膨出 形 楕円形 位置 中立〜亜端立 d.グラム染色性 + (2) 生育状態 a.肉汁寒天平板培養 平滑、色素生産せず b.肉汁寒天斜面培養 平滑、周辺なめらか、色素生産せず (3)生理学的性質 a.硝酸塩の還元 − b.脱窒反応 − c.MRテスト − d.VPテスト − e.インドールの生成 − f.硫化水素の生成 − g.デンプンの加水分解 + h.クエン酸の利用 − i.無機窒素源の利用 硝酸塩 − アンモニア塩 + j.ウレアーゼ − k.オキシダーゼ − l.カタラーゼ + m.生育の範囲 温度 10-37℃ n.酸素に対する態度 好気的 o.O−Fテスト −(酸の産生を認め
ず) p.糖類に対する態度 酸の生成 ガスの生成 (1)L-アラビノース − − (2)D-キシロース − − (3)D-グルコース + − (4)D-マンノース − − (5)D-フラクトース − − (6)D-ガラクトース + − (7)麦芽糖 + − (8)ショ糖 + − (9)乳糖 + − (10)トレハロース + − (11)D-ソルビット − − (12)D-マンニット − − (13)イノシット − − (14)グリセリン − − (15)デンプン + −
Next, a method for producing this substance will be described.
The microorganism used in the present invention may be any strain as long as it belongs to the genus Bacillus and produces a cyclic oligosaccharide from dextran, for example, T-304.
There are 0 strains. This T-3040 strain is a wild strain obtained from soil. The mycological properties of this strain are shown below. Mycological properties (1) Morphology a. Morphological bacilli b. Motility is observed c. Spores, sporangia, swelling, elliptical position Neutral to sub-edge d. Gram stainability + (2) Growth state a. Meat agar Plate culture Smooth, no pigment production b. Beef broth agar slope culture Smooth, peripheral smoothness, no pigment production (3) Physiological properties a. Reduction of nitrate-b. Denitrification reaction-c. MR test- d. VP test − E. Indole formation − f. Hydrogen sulfide formation − g. Starch hydrolysis + h. Use of citric acid − i. Use of inorganic nitrogen source Nitrate − Ammonia salt + j. Urease − k. Oxidase − l. Catalase + m. Growth range Temperature 10-37 ° C n. Attitude toward oxygen Aerobic o.O.F. test- (no acid production observed) p. Attitude toward sugars Acid production Gas production (1) L -Arabinose- (2) D-xylose- (3) D-glucose +-(4) D-mannose- (5) D-fructose − − (6) D-Galactose + − (7) Maltose + − (8) Sucrose + − (9) Lactose + − (10) Trehalose + − (11) D-Sorbit − − (12) D-Mannitol − − (13) Inosit − − (14) Glycerin − − (15) Starch + −

【0018】このT−3040菌株は、胞子を形成する
グラム陽性桿菌であることからバチルス属に属する細菌
であると同定し、バチルス属・エスピー. T−3040
株とした。なお、バチルス・エスピー.(Bacillus sp.)
T−3040株は、工業技術院微生物工業技術研究所
に微工研条寄第4132号(FERM BP−4132)として
寄託されている。
Since this T-3040 strain is a spore-forming Gram-positive bacillus, it was identified as a bacterium belonging to the genus Bacillus, and Bacillus sp. T-3040.
It was a stock. In addition, Bacillus sp. (Bacillus sp.)
The T-3040 strain has been deposited at the Institute of Microbial Science and Technology of the Agency of Industrial Science and Technology as Micromachine Research Article No. 4132 (FERM BP-4132).

【0019】本発明方法における菌株の培養は、原則的
には一般微生物の好気的培養で採用される方法と同じで
あるが、通常は、液体培地による振盪培養法または、通
気攪拌培養法等が用いられる。培地としては、通常の微
生物の培養に用いられる窒素源、炭素源、ビタミン、ミ
ネラル等を含みさらに本物質の原料となるデキストラン
等を含んだものが用いられる。
The culture of the strain in the method of the present invention is, in principle, the same as the method employed in the aerobic culture of general microorganisms, but usually, it is a shaking culture method using a liquid medium or an aeration stirring culture method. Is used. As the medium, a medium containing a nitrogen source, a carbon source, vitamins, minerals and the like, which are used for culturing ordinary microorganisms, and further containing dextran, which is a raw material of this substance, is used.

【0020】pHは、本菌が成育するpH域ならばいず
れでもよいが、通常は、6〜8の範囲が好ましい。培養
条件は、例えば、通常20〜40℃、好ましくは30℃で、16
時間〜6日間、好ましくは3日間振盪培養または通気攪
拌培養を行なう。
The pH may be in any pH range as long as the present bacterium grows, but is usually preferably in the range of 6-8. Culture conditions are, for example, usually 20 to 40 ° C., preferably 30 ° C., and 16
Shaking culture or aeration-agitation culture is performed for about 6 days, preferably 3 days.

【0021】以上の如くして得た培養物を用いて例え
ば、以下に示すオリゴ糖採取工程により本環状オリゴ糖
の精製品を得る。上記培養物からオリゴ糖を得るには遠
心分離、膜濃縮等により除菌したのち、通常のオリゴ糖
分離方法であれば如何なる方法でもよいが、本製造法の
場合、除菌液を公知のサイクロデキストリンの精製法に
従って処理することにより、高純度の環状オリゴ糖画分
を得ることが出来る。
The purified product of the present cyclic oligosaccharide is obtained using the culture obtained as described above, for example, by the oligosaccharide collecting step shown below. In order to obtain oligosaccharides from the above-mentioned culture, after sterilizing by centrifugation, membrane concentration, etc., any method can be used as long as it is a usual oligosaccharide separation method. By treating according to the purification method of dextrin, a highly pure cyclic oligosaccharide fraction can be obtained.

【0022】更に必要に応じて分配吸着モードのカラム
を用いたHPLC等の精製手段を用いて各々の高純度品
を得ることが出来る。除菌液からの、環状イソマルトオ
リゴ糖の精製法としては例えば、冷却処理、有機溶媒添
加処理、活性炭処理、あるいは特異的に環状オリゴ糖を
吸着するカラムクロマトグラフィー、活性炭カラムクロ
マトグラフィー等の公知方法で分離除去することができ
る。
Further, if necessary, each high-purity product can be obtained by using a purifying means such as HPLC using a column in a distribution adsorption mode. As a method for purifying cyclic isomalto-oligosaccharide from the sterilized liquid, for example, a known method such as cooling treatment, organic solvent addition treatment, activated carbon treatment, or column chromatography for specifically adsorbing cyclic oligosaccharide, activated carbon column chromatography, etc. Can be separated and removed.

【0023】以下に、本発明を実施例により具体的に説
明する。但し、本発明はこれら実施例によりその技術的
範囲が限定されるものではない。
The present invention will be specifically described below with reference to examples. However, the technical scope of the present invention is not limited by these examples.

【0024】[0024]

【実施例】1%デキストランT2000、1%ペプト
ン、0.5% NaCl及び0.1%イーストエキスからなる
液体培地(水道水使用、pH 7.0)3mlを15ml容試験管
に入れ、120℃で20分間、殺菌処理を行なった。これ
に、バチルス・エスピー. T−3040菌株(FERM
BP−4132) 保存スラントより1白金耳接種し、30℃
で1日間振盪培養した。本培養液3mlを上記と同様の培
地組成と殺滅菌条件により調製した2L の培地を含有す
る3L 容ミニジャ−に接種し、30℃、0.25vvm 、350r.
p. m. の条件で2日間通気攪拌培養を行ない、培養終了
後、培養液から8000r. p. m. で20分間の遠心分離処理
により菌体を分離し、除菌液を得た。
[Example] 3 ml of a liquid medium (using tap water, pH 7.0) consisting of 1% dextran T2000, 1% peptone, 0.5% NaCl and 0.1% yeast extract was placed in a 15 ml test tube and sterilized at 120 ° C for 20 minutes. Was done. In addition, Bacillus sp. T-3040 strain (FERM
BP-4132) Inoculate 1 platinum loop from stored slant at 30 ℃
The cells were cultivated with shaking for 1 day. 3 ml of the main culture broth was inoculated into a 3 liter mini jar containing 2 liter of medium prepared under the same medium composition and sterilization conditions as above, and then 30 ° C, 0.25vvm, 350r.
Aeration-agitation culture was carried out for 2 days under the condition of pm, and after the culture was completed, cells were separated from the culture by centrifugation at 8000 rpm for 20 minutes to obtain a sterilized solution.

【0025】除菌液を活性炭カラムに通液して環状イソ
マルトオリゴ糖を吸着させ、エタノールにより5%ず
つ、段階的に溶出した。20%エタノール溶出画分に目的
の環状オリゴ糖が最も多く含まれていた。本溶出液をロ
ータリーエバポレーターで濃縮後、TSKgel Am
ide80カラム(東ソ−社製、分配・吸着クロマトグラ
フィー用充填カラム)を用いたHPLCにより分析した
結果を図3−Aに示した。次に該粗環状イソマルトオリ
ゴ糖溶液をロータリーエバポレーターで濃縮後、YMC
PA43カラム(山村化学社製、分配・吸着クロマト
グラフィー用充填カラム、分取用)を用いたHPLCに
供し各々の環状イソマルトオリゴ糖を分離精製した。
The sterilized liquid was passed through an activated carbon column to adsorb cyclic isomalto-oligosaccharides, and then eluted stepwise by 5% each with ethanol. The 20% ethanol-eluted fraction contained most of the target cyclic oligosaccharide. After concentrating this eluate with a rotary evaporator, TSKgel Am
The results of HPLC analysis using an ide80 column (packing column for distribution / adsorption chromatography, manufactured by Toso Corp.) are shown in FIG. 3-A. Next, the crude cyclic isomalto-oligosaccharide solution was concentrated by a rotary evaporator and then concentrated with YMC.
Each cyclic isomalto-oligosaccharide was separated and purified by HPLC using a PA43 column (Yamamura Chemical Co., Ltd. packing column for partition / adsorption chromatography, for fractionation).

【0026】各々の画分をロータリーエバポレーターで
濃縮後、不純物として混入している直鎖イソマルトオリ
ゴ糖を除去するためにエキソ型デキストラナーゼである
グルコデキストラナーゼを添加して40℃で1晩反応させ
た。反応液を煮沸することにより反応を停止後、遠心分
離により変性蛋白質を除去した後、再度、YMC PA
43カラムを用いたHPLCにより各々の環状イソマルト
オリゴ糖を分離精製した。各々の画分をロータリーエバ
ポレーターで濃縮後、濃縮液中のオリゴ糖の純度をTS
Kgel Amide80カラム(東ソ−社製、分配・吸
着クロマトグラフィー用充填カラム)を用いたHPLC
により分析した(図3−B〜D)。各々のオリゴ糖の純
度は、98%以上であった。更に、これらのオリゴ糖画分
を凍結乾燥し、サイクロイソマルトヘプタオースを約60
mg、サイクロイソマルトオクタオースを約200mg 及びサ
イクロイソマルトノナオースを約100mg 得た。
After each fraction was concentrated with a rotary evaporator, glucodextranase, an exo-type dextranase, was added to remove linear isomaltooligosaccharides mixed as impurities, and the mixture was added at 40 ° C. overnight. It was made to react. After the reaction was stopped by boiling the reaction solution, the denatured protein was removed by centrifugation, and then YMC PA was added again.
Each cyclic isomaltooligosaccharide was separated and purified by HPLC using 43 columns. After concentrating each fraction with a rotary evaporator, the purity of oligosaccharide in the concentrate was
HPLC using Kgel Amide 80 column (manufactured by Toso Corporation, packed column for partition / adsorption chromatography)
Were analyzed by (Fig. 3-B-D). The purity of each oligosaccharide was 98% or more. Further, these oligosaccharide fractions were freeze-dried to obtain cycloisomaltoheptaose at about 60%.
mg, about 200 mg of cycloisomaltooctaose and about 100 mg of cycloisomaltononaose were obtained.

【0027】[0027]

【発明の効果】本発明により医薬品、食品等の包接剤と
して有用な新規なグルコースのα−1、6結合からなる
環状イソマルトオリゴ糖、及び当該環状イソマルトオリ
ゴ糖をバチルス属の微生物により高純度かつ効率良く製
造する方法を提供するものであって、産業上極めて有用
である。
INDUSTRIAL APPLICABILITY According to the present invention, a novel cyclic isomaltooligosaccharide consisting of α-1,6 bond of glucose, which is useful as a clathrate for medicines, foods, etc., and the cyclic isomaltooligosaccharide having a high purity by a Bacillus microorganism It also provides an efficient manufacturing method and is extremely useful industrially.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明化合物三種の赤外線吸収スペクトルを示
す図である。
FIG. 1 is a diagram showing infrared absorption spectra of three compounds of the present invention.

【図2】本発明化合物三種の酵素的解析結果を示す図で
ある。
FIG. 2 is a diagram showing the results of enzymatic analysis of three compounds of the present invention.

【図3】本発明化合物三種の溶出液及び生成した該化合
物3種をHPLCにより分析した結果 を示す図であ
る。
FIG. 3 is a diagram showing an eluate of three compounds of the present invention and the results of HPLC analysis of the produced three compounds.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 グルコース7分子がα−1、6結合によ
り環状構造を形成してなる新規なサイクロイソマルトヘ
プタオース、グルコース8分子がα−1、6結合により
環状構造を形成してなる新規なサイクロイソマルトオク
タオース及びグルコース9分子がα−1、6結合により
環状構造を形成してなる新規なサイクロイソマルトノナ
オースからなる群から選択された新規な環状イソマルト
オリゴ糖。
1. A novel cycloisomaltoheptaose in which 7 molecules of glucose form a cyclic structure by α-1,6 bonds, and a novel cycloisomaltoheptaose in which 8 molecules of glucose form a cyclic structure by α-1,6 bonds Cycloisomaltooctaose and a novel cyclic isomaltonosaccharide selected from the group consisting of novel cycloisomaltononaose, in which 9 molecules of glucose form a cyclic structure by α-1,6 bonds.
【請求項2】 バチルス属に属し、請求項1記載の環状
イソマルトオリゴ糖生産能を有する微生物を、α−1、
6グルカンを含有する培地中で培養し、培養物より請求
項1記載の環状イソマルトオリゴ糖を採取することを特
徴とする新規な環状イソマルトオリゴ糖の製造法。
2. A microorganism belonging to the genus Bacillus and having a cyclic isomaltooligosaccharide-producing ability according to claim 1, is α-1,
A novel method for producing a cyclic isomaltooligosaccharide, which comprises culturing in a medium containing 6-glucan and collecting the cyclic isomaltooligosaccharide according to claim 1 from the culture.
JP34944492A 1992-12-28 1992-12-28 Novel cyclic isomaltooligosaccharide and method for producing the same Expired - Lifetime JP3075873B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP34944492A JP3075873B2 (en) 1992-12-28 1992-12-28 Novel cyclic isomaltooligosaccharide and method for producing the same
DE69308531T DE69308531T2 (en) 1992-12-28 1993-12-24 Cycloisomaltooligosaccharides; Enzyme and process for its preparation, and process for its production
EP93310579A EP0608636B1 (en) 1992-12-28 1993-12-24 Cycloisomaltooligosaccharides, an enzyme and process for producing said oligosaccharides, and a process for producing said enzyme
US08/174,596 US5364936A (en) 1992-12-28 1993-12-28 Cycloisomaltooligosaccharides
US08/284,318 US5453369A (en) 1992-12-28 1994-08-02 Enzyme for producing novel cyclooisomaltooligosaccharides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34944492A JP3075873B2 (en) 1992-12-28 1992-12-28 Novel cyclic isomaltooligosaccharide and method for producing the same

Publications (2)

Publication Number Publication Date
JPH06197783A true JPH06197783A (en) 1994-07-19
JP3075873B2 JP3075873B2 (en) 2000-08-14

Family

ID=18403796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP34944492A Expired - Lifetime JP3075873B2 (en) 1992-12-28 1992-12-28 Novel cyclic isomaltooligosaccharide and method for producing the same

Country Status (1)

Country Link
JP (1) JP3075873B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006280254A (en) * 2005-03-31 2006-10-19 Showa Sangyo Co Ltd Novel uses of 3-4 saccharides having a branched structure, inhibitors containing these saccharides as active ingredients, and food and drink
JP2012140521A (en) * 2010-12-28 2012-07-26 Osaka Prefecture Univ METHOD FOR USING α-1,3-BRANCHED CYCLODEXTRAN
WO2020122050A1 (en) 2018-12-13 2020-06-18 株式会社林原 Cycloisomaltotetraose, cycloisomaltotetraose production enzyme, and production methods and uses thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006280254A (en) * 2005-03-31 2006-10-19 Showa Sangyo Co Ltd Novel uses of 3-4 saccharides having a branched structure, inhibitors containing these saccharides as active ingredients, and food and drink
JP4667101B2 (en) * 2005-03-31 2011-04-06 昭和産業株式会社 Novel uses of tetrasaccharides having a branched structure, inhibitors containing these saccharides as active ingredients
JP2012140521A (en) * 2010-12-28 2012-07-26 Osaka Prefecture Univ METHOD FOR USING α-1,3-BRANCHED CYCLODEXTRAN
WO2020122050A1 (en) 2018-12-13 2020-06-18 株式会社林原 Cycloisomaltotetraose, cycloisomaltotetraose production enzyme, and production methods and uses thereof
KR20210104074A (en) 2018-12-13 2021-08-24 가부시기가이샤하야시바라 Cycloisomaltotetraose, cycloisomaltotetraose synthase, and method and use thereof

Also Published As

Publication number Publication date
JP3075873B2 (en) 2000-08-14

Similar Documents

Publication Publication Date Title
US5364936A (en) Cycloisomaltooligosaccharides
JP3075873B2 (en) Novel cyclic isomaltooligosaccharide and method for producing the same
JP2654825B2 (en) Novel cyclic inulooligosaccharide and method for producing the same
JP3117328B2 (en) Novel cyclic isomatooligosaccharide synthase, method for producing the same, and method for producing cyclic isomatooligosaccharide
JP3400868B2 (en) Anti-caries agent
JP3673302B2 (en) Branched cycloisomaltoheptaose and process for producing the same
JPS6066987A (en) Antibiotic substance tan-547, production thereof and microorganism
US4169889A (en) Antibiotic bn-200 substance and process for production thereof
JPS61101501A (en) Carcinostatic polysaccharide and its production
JPH05199864A (en) Klebsilella oxytoca no.19-1 and preparation of alpha cyclodextrin using klebsilella oxytoca no. 19-1
US5492829A (en) Klebsiella oxytoca No. 19-1 capable of producing α-cyclodextrin
KR100511419B1 (en) beta-fructosyl-L-ascorbic acid and the preparation method thereof
JPH1036406A (en) Galactosyl-cycloisomaltooligosaccharide and method for producing the same
KR830002250B1 (en) Preparation of Cyclodextrine
JPH0823989A (en) Production of oligosaccharide having high panose content
JPS5811838B2 (en) Shinko Seibutsutsu BN-165 Shinko Seizouhou
JPS6135832B2 (en)
JPH06113843A (en) New cyclodextrin glucanotransferase produced by bacillus megateruim, its production, its production and production of cyclodextrin using the same enzyme
JPS637792A (en) Production of n,n'-diacetylchitobiose by microorganism
JPH0479892A (en) Production of fr-901228 substance
JPH078284A (en) Production of oligosaccharide containing panose
JPH06298791A (en) Stevioside-sugar transfer compound and its production
JPH0258280B2 (en)
JPH03127798A (en) Physiologically active substance syringostatin and its manufacturing method
JPH0733736A (en) New antibiotic adisemycin B and method for producing the same

Legal Events

Date Code Title Description
FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090609

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090609

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090609

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 9

Free format text: PAYMENT UNTIL: 20090609

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100609

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 10

Free format text: PAYMENT UNTIL: 20100609

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110609

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 12

Free format text: PAYMENT UNTIL: 20120609

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 12

Free format text: PAYMENT UNTIL: 20120609

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120609

Year of fee payment: 12

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120609

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 12

Free format text: PAYMENT UNTIL: 20120609

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120609

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130609

Year of fee payment: 13

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 13

Free format text: PAYMENT UNTIL: 20130609